Vertex Pharmaceuticals Incorporated
IT ˙ BIT ˙ US92532F1003
366,30 € ↓ -1,30 (-0,35%)
2026-06-03
AKTIENPREIS
SecurityIT:1VRTX / Vertex Pharmaceuticals Incorporated
InstitutionMather Group, Llc.
Latest Disclosed Ownership4,438 shares
Latest Disclosed Value $ 1,981,932
Mather Group, Llc. reports 0.29% increase in ownership of 1VRTX / Vertex Pharmaceuticals Incorporated

On April 13, 2026 - Mather Group, Llc. filed a 13F-HR form disclosing ownership of 4,438 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $1,684,665 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 13, 2026 disclosing 4,425 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 0.29% during the quarter. The current value of the position is $1,625,639 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,438 13 0.29 1,982 -1.25 0.0198
2026-01-13 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,425 86 1.98 2,006 18.07 0.0207
2025-10-21 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,339 23 0.53 1,699 -11.56 0.0172
2025-07-15 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,316 170 4.10 1,921 -4.38 0.0205
2025-04-25 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,146 259 6.66 2,010 28.37 0.0232
2025-01-27 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,887 -128 -3.19 1,565 -16.18 0.0203
2024-10-07 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,015 80 2.03 1,867 13.56 0.0240
2024-07-09 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,935 398 11.25 1,645 14.25 0.0203
2024-04-09 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,537 -104 -2.86 1,439 -2.84 0.0227
2024-02-05 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,641 49 1.36 1,481 18.67 0.0232
2023-11-13 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,592 422 13.31 1,249 11.93 0.0222
2023-08-08 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,170 287 9.95 1,115 22.80 0.0178
2023-05-09 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,883 0 0.00 908 9.13 0.0161
2023-03-10 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,883 102 3.67 833 3.35 0.0160
2022-11-15 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,781 231 9.06 805 11.96 0.0173
2022-08-16 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,550 264 11.55 719 20.64 0.0164
2022-05-13 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,286 2,286 596 0.0118
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.